Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (taxol)

Cancer Research

Volumn 56, Issue 5, 1996, Pages 1091-1097

  Dumontet, Charles ^a   Duran, George E ^a   Steger, Katherine A ^a   Beketic Oreskovic, Lidija ^a   Sikic, Branimir I ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; PACLITAXEL; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL SUBPOPULATION; CELL SURVIVAL; CROSS RESISTANCE; CYTOTOXICITY; DELETION MUTANT; DRUG EXPOSURE; DRUG MECHANISM; GENE TARGETING; MICROTUBULE ASSEMBLY; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA CELL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; DRUG RESISTANCE; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; P-GLYCOPROTEIN; PACLITAXEL; SARCOMA; TUBULIN; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0030022120     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wall, M E., and Wani, M. C. Camptothecin and taxol: discovery to clinic - Thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res , 55: 753-760, 1995
2. Gelmon, K. A Biweekly paclitaxel (Taxol) and cisplatin in breast and ovarian cancer. Semin. Oncol , 21: 24-28, 1994.
3. Caldas, C., and McGuire, W. P. Taxol in epithelial ovarian cancer. J. Natl. Cancer Inst Monogr, 15: 155-159, 1993.
4. Parness, J., and Horwitz, S B. Taxol binds to polymerized tubulin in vitro. J Cell Biol., 91: 479-487, 1981.
5. Horwitz, S. B., Cohen, D , Rao, S., Ringel, I., Shen, H. J., and Yang, C. P. Taxol. mechanisms of action and resistance. J Natl. Cancer Inst. Monogr., 15: 55-61, 1993.
6. Schibler, M. J , and Cabral, F. Taxol-dependent mutants of Chinese hamster ovary cells with alterations in α- and α-tubulin. J. Cell Biol., 102: 1522-1531, 1986.
7. Ohta, S., Nishio, K., Kubota, N , Ohmori, T., Funayama, Y., Ohira, T., Nakajima, H , Adachi, M., and Saijo, N. Characterization of a taxol-resistant human small-cell lung cancer cell line. Jpn. J. Cancer Res., & 85: 290-297, 1994.
8. Luria, S E., and Delbruck, M. Mutation of bacteria from virus sensitivity to virus resistance. Genetics., 28: 491-499, 1943.
9. Harker, W G., MacKintosh, F. R. and Sikic, B I Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drugs. Cancer Res., 43, 4943-4950, 1983.
10. Harker, W. G., and Sikic, B. I. Mutidrug (pleiotropic) resistance in doxorubicin-selected variant, the human sarcoma cell line MES-SA. Cancer Res., 45: 4091-4096 1985.
11. Catcheside, D. G The Genetics of Microorganisms, p 158. London: Sir Issac Pitman and Sons, 1951.
12. Twentyman, P. R., Fox, N. E., and Rees, J. K. Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. Br. J. Haematol., 71: 19-24, 1989.
13. Sullivan, K. F. Structure and utilization of tubulin isotypes. Annu. Rev. Cell Biol., 4: 687-716, 1988.
14. Lewis, S. A., Gilmartin, M. E., Hall, J. L., and Cowan, N. J. Three expressed sequences within the human β-tubulin multigene family each define a distinct isotype J. Mol. Biol , 182: 11-20, 1985.
15. Cowan, N. J., Lewis, S. A., Sarkar, S., and Gu, W. Functional versatility of mammalian β-tubulin isotypes. In: R. Maccioni and J. Arechaga (eds.), The Cytoskeleton in Cell Differentiation and Development, pp. 157-166. Paris, France: ICSU Press, 1986.
16. Chen, G., Jaffrezou, J. P , Fleming, W H., Duran, G. E., and Sikic, B. I Prevalence of multidrug resistance related to activation of the mdr-1 gene in human sarcoma mutants derived by single-step doxorubicin selection. Cancer Res., 54: 4980-4987, 1994.
17. Cook, J. A., Pass, H. I., Iype, S. N., Friedman, N., DeGraff, W., Russo, A , and Mitchell, J. B. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue. Cancer Res., 51: 4287-4294, 1991.
18. Lowry, O. H , Rosebrough, N J., Farr, A L , and Randall, R. J. Protein measurement with Folin phenol reagent. J. Biol. Chem , 193: 265-275, 1951.
19. Liebmann, J. E. Hahn, S. M , Cook, J. A., Lipschultz, C., Mitchell, J. B., and Kaufman, D C. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res., 53: 2066-2070, 1993
20. Sullivan, K. F., and Cleveland, D. W. Sequence of a highly divergent beta tubulin gene reveals regional heterogeneity in the beta tubulin polypeptide J. Cell Biol. 99: 1754-1760, 1984.
21. Wilde, C. D., Crowther, C. E., Cripe, T. P., Gwo-Shu Lee, M., and Cowan, N J Evidence that a human β-tubulin pseudogene is derived from its corresponding mRNA. Nature (Lond), 297: 83-84, 1982.
22. Cabral, F., and Barlow, S. B. Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly. FASEB J., 3: 1593-1599, 1989.
23. Law, L. W. Origin of resistance of leukaemic cells to folic acid antagonists. Nature (Lond.), 169: 628-629, 1952
24. Kendal, W. S. and Frost, P. Pitfalls and practice of Luria-Delbruck fluctuation analysis: a review. Cancer Res., 48: 1060-1065, 1988.
25. Rao, S., Krauss, N. E., Heerding, J. M., Swindell, C S., Ringel, I., Orr, G A , and Horwitz, S. B. 3́-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of β-tubulin. J. Biol. Chem., 269: 3132-3134, 1994.
26. Combeau, C., Commercon, A., Mioskowski, C., Rousseau, B., Aubert, F. and Goeldner, M. Predominant labeling of β- over α-tubulin from porcine brain by a photoactivatable taxoid derivative. Biochemistry 33: 6676-6683, 1994.
27. Cabral, F., Sobel, M. E , and Gottesman, M. M. CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered β-tubulin. Cell, 20: 29-36, 1980.
28. Haber, M., Burkhart, C. A., Regl, D., Madafiglio, J., Norris, M. D., and Horwitz, S. B Taxol resistance in J774.2 cells is associated with altered expression of specific β-tubulin isotypes. Proc. Am. Assoc. Cancer Res., 36, 318, 1995.
29. Giannakakou, P., Sackett, D , Mickley, L., Kang, Y. K., Fojo, A. T., and Poruchynsky, M. Characterization of non-Pgp paclitaxel resistance in the human ovarian cancer cell line A2780. Proc. Am. Assoc. Cancer Res., 36: 456, 1995.
30. Minotti, A. M., Barlow, S. B., and Cabral, F. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin. J. Biol Chem., 266: 3987-3994, 1991.
31. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations Proc. Natl Acad. Sci. USA, 90: 9552-9556, 1993.
32. Boggs, B. A., Gonzalez-Garay, M. L., O'Brien, W. F., Barlow, S. B., and Cabral, F. Mechanisms of resistance to drugs that target microtubules. Cell. Pharmacol., J (Suppl. 1): S95-S101, 1993.
33. Cabral, F., and Barlow, S. B. Resistance to antimitotic agents as genetic probes of microtubule structure and function. Pharmacol. & Ther., 52, 159-171, 1991.
34. Cleveland, D. W., and Sullivan, K. F. Molecular biology and genetics of tubulin Annu. Rev. Biochem., 54: 331-365, 1985.
35. Luduena, R. F. Are tubulin isotypes functionally significant? Mol. Biol. Cell, 4: 445-457, 1993
36. Raff, E C. The role of multiple tubulin isoforms in cellular microtubule function. In: J. S. Hyams and C. W Lloyd (eds.), Microtubules, pp. 85-109 New York. Wiley-Liss, Inc., 1994.
37. Panda, D., Miller, H. P., Banerjee, A., Luduena, R F , and Wilson, L. Microtubule dynamics in vitro are regulated by the cubulin isotype composition. Proc. Natl. Acad. Sci. USA, 91: 11358-11362, 1994.
38. Lewis, S. A., Gu, W , and Cowan, N J. Free intermingling of mammalian β-tubulin isotypes among functionally distinct microtubules. Cell, 49: 539-548, 1987
39. Yen, T J., Gay, D. A., Pachter, J. S., and Cleveland, D. W. Autoregulated changes in stability of polyribosome-bound beta-tubulin mRNAs are specified by the first 13 translated nucleotides. Mol. Cell. Biol., 8: 1224-1235, 1988.
40. Marchesi, V. T., and Ngo, N In vitro assembly of multiprotein complexes containing α, β, and γ tubulin, heat shock protein HSP70, and elongation factor 1 alpha. Proc. Natl. Acad. Sci. USA, 90: 3028-3032, 1993.
41. Gao, Y , Vainberg, I. E , Chow, R. L., and Cowan, N. J. Two cofactors and cytoplasmic chaperonin are required for the folding of α- and β-tubulin. Mol. Cell. Biol., 13: 2478-2485, 1993.
42. Sisodia, S. S., Gay, D. A., and Cleveland, D. W. In vivo discrimination among β-tubulin isotypes: selective degradation of a type IV beta-tubulin isotype following overexpression in cultured animal cells. New Biol., 2: 66-76, 1990
43. Jaffrezou, J. P , Chen, G , Duran, G. E., Kuhl, J. S., and Sikic, B. I. Mutation rates and mechanisms of resistance to etoposide determined from fluctuation analysis. J. Natl. Cancer Inst., 86: 1152-1158, 1994.